Glenmark Life Sciences is launching its IPO. The public offer comprises a fresh issue of equity shares worth Rs. 1,160 crores and offer for sale of 63 lakh equity shares by its parent company Glenmark Pharmaceuticals Ltd.Don't have a Tradeplus account? Sign up
Glenmark Life Sciences is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs) catering to chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management, and diabetes, among others. As of December 31, 2020, the company had a portfolio of 120 molecules globally and sold its APIs in India as well as to multiple countries in Europe, North America, Latin America, Japan, and the rest of the world. Read more
|Financial Year Ended||Revenue (₹ Millions)||Profit After Tax (₹ Millions)||EPS (₹)|
You can apply for the Glenmark Life Sciences IPO using any supported UPI app by following two steps:
On acceptance of the mandate, the bid amount will get blocked in your bank account. Click here to learn more.
I'm a cool paragraph that lives inside of an even cooler modal. Wins!
You will receive an OTP on your mobile